Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Banco Votorantim $100 million reopening of notes under global MTN program
Davis Polk advised Banco Votorantim S.A. in connection with the offering of $100 million aggregate principal amount of its 4…
Decarbonization Plus Acquisition $200 million IPO
Davis Polk advised the underwriters in connection with the $200 million initial public offering of 20,000,000 units of…
Primo Water Holdings €450 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S…
Promigas and Gases del Pacífico $120 million notes offering
Davis Polk advised the initial purchasers in connection with the offering by Promigas S.A. E.S.P. and its subsidiary…
Primo Water Holdings €450 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S…
Promigas and Gases del Pacífico $120 million notes offering
Davis Polk advised the initial purchasers in connection with the offering by Promigas S.A. E.S.P. and its subsidiary…
Morgan Stanley $1 billion inaugural offering of social bonds
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $1 billion aggregate principal…
Morgan Stanley $1 billion inaugural offering of social bonds
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $1 billion aggregate principal…
Morgan Stanley $1 billion inaugural offering of social bonds
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $1 billion aggregate principal…
Royalty Pharma $728 million secondary offering
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $728 million secondary offering of 17…